A prospective, controlled multisite trial of yoga in pediatric inflammatory bowel disease

被引:1
|
作者
Leiby, Alycia [1 ,2 ,7 ]
Albenberg, Lindsey [3 ]
Langseder, Annette [1 ]
Kennedy, Mary [1 ]
Pressman, Naomi [3 ]
Chiu, Stephanie [4 ]
Rosh, Joel R. [5 ,6 ]
机构
[1] Atlantic Hlth Syst, Atlantic Childrens Hlth Goryeb Childrens Hosp, Div Pediat Gastroenterol & Nutr, Morristown, NJ USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA USA
[3] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA USA
[4] Atlantic Hlth Syst, Atlantic Ctr Res, Morristown, NJ USA
[5] Steven & Alexandra Cohen Childrens Med Ctr New Yor, Div Pediat Gastroenterol Liver Dis & Nutr, New York, NY USA
[6] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Pediat, Lake Success, NY USA
[7] Atlantic Hlth Syst, Atlantic Childrens Hlth Goryeb Childrens Hosp, Pediat Gastroenterol & Nutr, 100 Madison Ave, Morristown, NJ 07960 USA
关键词
Crohn's disease; mind-body; quality of life; ulcerative colitis; QUALITY-OF-LIFE; COGNITIVE-BEHAVIORAL THERAPY; ALTERNATIVE MEDICINE USE; ABDOMINAL-PAIN; ADOLESCENTS; CHILDREN; OUTCOMES; COMPLEMENTARY; POPULATION; PREVALENCE;
D O I
10.1002/jpn3.12081
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimTo investigate whether a structured yoga program improves health-related quality of life (HRQOL) and self-efficacy in pediatric patients receiving care for inflammatory bowel disease (IBD).MethodsIBD patients who were 10-17 years old participated in a 12 week, in-person yoga intervention at two clinical sites. Outcomes were measured at time of consent (T0), start of yoga (T1), and completion of yoga (T2) and 3 months after yoga completion (T3) using the IMPACT-III, Pediatric Quality of Life Inventory (PedsQL), and General Self Efficacy (GSE) scales.ResultsSeventy-eight patients were enrolled. Fifty-six patients completed nine or more classes. 73.2% had Crohn's disease and 26.8% ulcerative colitis or IBD-unclassified. A significant increase in IMPACT-III was seen from T1 to T3 (mean change of 5.22, SD = 14.33, p = 0.010), in the PedsQL (mean change = 2.3, SD = 10.24, p = 0.050), and GSE (mean change = 1, SD = 3.60, p = 0.046). 85.2% of patients reported yoga helped them to control stress. Long-term data was available for 47 subjects with 31.9% (n = 15) continuing to practice yoga one to 3 years after study completion.ConclusionThis structured 12-week yoga program showed significant improvements in HRQOL and general self-efficacy, particularly 3 months after classes were concluded suggesting that yoga's benefits may persist. Yoga is a safe and effective adjunct to standard medical care to improve QOL and self-efficacy in youth with IBD. What is Known Complementary and alternative medicine use in pediatric inflammatory bowel disease (IBD) is high, particularly in patients with greater disease activity as well as those with a lower quality of life. Yoga has been studied as an intervention in other chronic disease states such as pain disorders, anxiety, and depression. Use of yoga is relatively low in the pediatric IBD population. Pilot studies have demonstrated yoga in pediatric IBD to be feasible and safe.What is New The practice of yoga is associated with improvements in quality of life (QOL) and self-efficacy scores in youth with IBD. In youth with IBD, improvements in QOL and self-efficacy persist beyond the period of structured yoga practice.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 50 条
  • [1] A Randomized, Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease: Preliminary Findings
    Leiby, Alycia
    Langseder, Annette
    Bustami, Rami
    Vazirani, Minal
    Marchell, Madeline
    Ferrara, Madelana
    Rosh, Joel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S594 - S594
  • [2] A prospective, case-controlled trial of practice guidelines in inflammatory bowel disease (IBD).
    Tremaine, WJ
    Sandborn, WJ
    Loftus, EV
    Kenan, ME
    Petterson, TM
    Zinsmeister, AR
    Silverstein, MD
    GASTROENTEROLOGY, 2000, 118 (04) : A783 - A783
  • [3] Yoga as adjunct therapy for adolescents with inflammatory bowel disease: A pilot clinical trial
    Arruda, Jenna M.
    Bogetz, Alyssa L.
    Vellanki, Srisindu
    Wren, Anava
    Yeh, Ann Ming
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 41 : 99 - 104
  • [4] Efficacy of patient education in chronic inflammatory bowel disease in a prospective controlled multicenter trial.
    Schreiber, S
    Hamling, J
    Wedel, S
    Nikolaus, SN
    Buhr, HJ
    Raedler, A
    GASTROENTEROLOGY, 1999, 116 (04) : A815 - A815
  • [5] Prospective Randomized Trial of a Progressive Pediatric to Adult Transition of Care Program in Adolescents With Inflammatory Bowel Disease
    Moulton, Dedrick E.
    Rosen, Michael J.
    Beaulieu, Dawn B.
    Horst, Sara N.
    Schwartz, David A.
    GASTROENTEROLOGY, 2013, 144 (05) : S532 - S532
  • [6] Pediatric Inflammatory Bowel Disease
    Bouhuys, Marleen
    Lexmond, Willem S.
    van Rheenen, Patrick F.
    PEDIATRICS, 2023, 151 (01)
  • [7] Pediatric inflammatory bowel disease
    Antonioli, DA
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2005, 8 (01) : 2 - 19
  • [8] Pediatric inflammatory bowel disease
    Diefenbach, Karen A.
    Breuer, Christopher K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (20) : 3204 - 3212
  • [9] Pediatric inflammatory bowel disease
    Eric Vasiliauskas
    Current Treatment Options in Gastroenterology, 2000, 3 (5) : 403 - 424
  • [10] Pediatric inflammatory bowel disease
    Akshay Kapoor
    Vidyut Bhatia
    Anupam Sibal
    Indian Pediatrics, 2016, 53 : 993 - 1002